DAY 1 (9:00-5:00 pm)

9:00-9:05 am - Welcome & Housekeeping

SYMPOSIUM 1 (9:05-1:00 pm)

9:05-12:00 pm - Curative Therapies in Sickle Cell Disease
11:00-11:10 am - BREAK
12:00-1:30 pm - BMT for Adults With Sickle Cell Disease: STRIDE Pilot Study

SYMPOSIUM 2 (1:00-5:00 pm)

1:00-2:00 pm - The Role of Cannabinoids in Sickle Cell Disease
2:00-3:30 pm - DBDR-CURE SCD-NIH-GATES Consortium
3:30-5:00 pm - SCDIC Session- Sharon Smith, PhD, Division of Blood Diseases & Resources
3:30-3:45 pm - Overview of the Sickle Cell Disease Implementation Consortium-SCDIC and a Protocol to Improve
ED Care using Individualized Pain Plans
3:45-3:55 pm - Early Findings from the Integration of mHealth into the Care of Patients with Sickle Cell Disease
to Increase Hydroxyurea Utilization (mESH Study)
3:55-4:05 pm - Moving the Needle in Sickle Cell Care: Expert Consensus on What Determines an Unaffiliated
Patient
4:05-4:20 pm - Question & Answer Session
4:20-4:30 pm - Quality of Care Among Adolescents and Adults with SCD in the US
4:30-4:40 pm - Patient Reported Outcomes in the Sickle Cell Disease Implementation Consortium Registry
4:40-4:50 pm - Hydroxyurea is Associated with Miscarriage and Stillbirth
4:50-5:00 pm - Victor Gordeuk, MD, University of Illinois at Chicago

QUESTION AND ANSWER SESSION
ADJOURN
----------------------------------------------------------------------------------

DAY 2 (9:00-5:00 pm)

9:00-9:10 am - Welcome & Housekeeping

SYMPOSIUM 3 (9:00-1:00 pm)

9:10-9:45 am - Fertility and Fertility Preservation for Women With SCD
9:45-10:40 am - Contraception
10:40-11:00 am - Summary Unified - Interactive/Integrated
11:00-11:10 am - BREAK
11:10-12:10 pm - SCD-CARRE
12:10-1:00 pm - Heymolysis & Immune Complications in SCD
1:00-1:10 pm - BREAK

SYMPOSIUM 4 (1:10-5:00 pm)

1:10-2:10 pm - Reviewing the Results
2:10-5:00 pm -SCAPN- Sickle Cell Adult Provider Network

QUESTION AND ANSWER SESSION
ADJOURN
----------------------------------------------------------------------------------

DAY 3 (9:00-4:00 pm)

9:00-9:05 am - WELCOME & HOUSEKEEPING

SYMPOSIUM 5 (9:00-12:00 pm)

9:05-9:35 am - Essential Features of Sickle Cell Centers: Summary of the Evidence & a Consensus
9:35-10:30 am - Essential Features of Sickle Cell Centers: Summary of the Evidence & a Consensus
10:30-10:45 am - BREAK
10:45-11:45 am - Getting Administrative Buy-In & Writing a Business Plan
11:45-12:45 pm - COVID-19 Telemedicine & Re-Imaging the Adult Care Model (TBD)
12:45-1:00 pm - BREAK

SYMPOSIUM 6 (1:00-3:30 pm)

1:00-1:20 pm - ASH Sickle Cell Initiative
1:20-1:40 pm - Quantification of Cerebral Metabolic Rate of Oxygen (CMRO2) in SCD
1:40-2:00 pm - Wednesday Continued
2:00-2:20 pm - Protection Against Vaso-Occlusion With Daily Dosing of HBI-002, a Low Dose Oral Carbon
Monoxide Formulation, In Sickle Cell Disease Mouse Models
2:20-2:30 pm - The Many Facets of KYC for Improving Vascular Function in SCD
2:30-4:00 pm - Session
2:30-2:45 pm - Ketamine and Novel Approached to Pain Management in the Sickle Cell Patient With Acute Pain
2:45-3:00 pm - Ketamine and Novel Approached to Pain Management in the Sickle Cell Patient With Acute Pain
3:00-3:15 pm - Intensive Training Program for Multidisciplinary Health Providers in Adult Sickle Cell Disease
3:15-3:30 pm - Novel Laboratory Techniques To Determine Red Cell Health And Complication Risk In Patients
Receiving Experimental Therapy
3:30-3:45 pm - Iron Dysregulation in Sickle Cell Disease and its Clinical Effects and Management
3:45-4:00 pm - QUESTION AND ANSWER SESSION

CONFERENCE ADJOURNMENT